Cargando…

Serum homocysteine and risk of dementia in Japan

OBJECTIVE: To examine the association between serum total homocysteine levels (tHcy) and dementia risk. METHODS: A total of 1588 Japanese adults aged ≥60 years without dementia were prospectively followed from 2002 to 2012. Cox proportional hazards models and restricted cubic splines were used to es...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Sanmei, Honda, Takanori, Ohara, Tomoyuki, Hata, Jun, Hirakawa, Yoichiro, Yoshida, Daigo, Shibata, Mao, Sakata, Satoko, Oishi, Emi, Furuta, Yoshihiko, Kitazono, Takanari, Ninomiya, Toshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231445/
https://www.ncbi.nlm.nih.gov/pubmed/32234968
http://dx.doi.org/10.1136/jnnp-2019-322366
_version_ 1783535191671701504
author Chen, Sanmei
Honda, Takanori
Ohara, Tomoyuki
Hata, Jun
Hirakawa, Yoichiro
Yoshida, Daigo
Shibata, Mao
Sakata, Satoko
Oishi, Emi
Furuta, Yoshihiko
Kitazono, Takanari
Ninomiya, Toshiharu
author_facet Chen, Sanmei
Honda, Takanori
Ohara, Tomoyuki
Hata, Jun
Hirakawa, Yoichiro
Yoshida, Daigo
Shibata, Mao
Sakata, Satoko
Oishi, Emi
Furuta, Yoshihiko
Kitazono, Takanari
Ninomiya, Toshiharu
author_sort Chen, Sanmei
collection PubMed
description OBJECTIVE: To examine the association between serum total homocysteine levels (tHcy) and dementia risk. METHODS: A total of 1588 Japanese adults aged ≥60 years without dementia were prospectively followed from 2002 to 2012. Cox proportional hazards models and restricted cubic splines were used to estimate the HRs of tHcy levels on the risk of dementia. RESULTS: During the follow-up, 372 subjects developed all-cause dementia; 247 had Alzheimer’s disease (AD) and 98 had vascular dementia (VaD). Compared with the lowest tHcy quintile (≤6.4 µmol/L), the multivariable-adjusted HRs (95% CI) of the highest quintile (≥11.5 µmol/L) were 2.28 (1.51–3.43) for all-cause dementia, 1.96 (1.19–3.24) for AD and 2.51 (1.14–5.51) for VaD. In restricted cubic splines, the risk of all-cause dementia steadily increased between approximately 8–15 µmol/L and plateaued thereafter, with a similar non-linear shape observed for AD and VaD (all p for non-linearity ≤0.02). In stratified analyses by the most recognised genetic polymorphism affecting tHcy concentrations (methylenetetrahydrofolate reductase C677T), the positive association of tHcy with all-cause dementia persisted in both non-carriers and carriers of the risk allele, and even tended to be stronger in the former (p for heterogeneity=0.07). CONCLUSION: High serum tHcy levels are associated with an elevated risk of dementia, AD and VaD in a non-linear manner, such that an exposure-response association is present only within a relatively high range of tHcy levels. Non-genetic factors affecting serum tHcy concentrations may play important roles in tHcy-dementia associations irrespective of the genetic susceptibility for raised tHcy.
format Online
Article
Text
id pubmed-7231445
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-72314452020-05-18 Serum homocysteine and risk of dementia in Japan Chen, Sanmei Honda, Takanori Ohara, Tomoyuki Hata, Jun Hirakawa, Yoichiro Yoshida, Daigo Shibata, Mao Sakata, Satoko Oishi, Emi Furuta, Yoshihiko Kitazono, Takanari Ninomiya, Toshiharu J Neurol Neurosurg Psychiatry Neuropsychiatry OBJECTIVE: To examine the association between serum total homocysteine levels (tHcy) and dementia risk. METHODS: A total of 1588 Japanese adults aged ≥60 years without dementia were prospectively followed from 2002 to 2012. Cox proportional hazards models and restricted cubic splines were used to estimate the HRs of tHcy levels on the risk of dementia. RESULTS: During the follow-up, 372 subjects developed all-cause dementia; 247 had Alzheimer’s disease (AD) and 98 had vascular dementia (VaD). Compared with the lowest tHcy quintile (≤6.4 µmol/L), the multivariable-adjusted HRs (95% CI) of the highest quintile (≥11.5 µmol/L) were 2.28 (1.51–3.43) for all-cause dementia, 1.96 (1.19–3.24) for AD and 2.51 (1.14–5.51) for VaD. In restricted cubic splines, the risk of all-cause dementia steadily increased between approximately 8–15 µmol/L and plateaued thereafter, with a similar non-linear shape observed for AD and VaD (all p for non-linearity ≤0.02). In stratified analyses by the most recognised genetic polymorphism affecting tHcy concentrations (methylenetetrahydrofolate reductase C677T), the positive association of tHcy with all-cause dementia persisted in both non-carriers and carriers of the risk allele, and even tended to be stronger in the former (p for heterogeneity=0.07). CONCLUSION: High serum tHcy levels are associated with an elevated risk of dementia, AD and VaD in a non-linear manner, such that an exposure-response association is present only within a relatively high range of tHcy levels. Non-genetic factors affecting serum tHcy concentrations may play important roles in tHcy-dementia associations irrespective of the genetic susceptibility for raised tHcy. BMJ Publishing Group 2020-05 2020-03-31 /pmc/articles/PMC7231445/ /pubmed/32234968 http://dx.doi.org/10.1136/jnnp-2019-322366 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Neuropsychiatry
Chen, Sanmei
Honda, Takanori
Ohara, Tomoyuki
Hata, Jun
Hirakawa, Yoichiro
Yoshida, Daigo
Shibata, Mao
Sakata, Satoko
Oishi, Emi
Furuta, Yoshihiko
Kitazono, Takanari
Ninomiya, Toshiharu
Serum homocysteine and risk of dementia in Japan
title Serum homocysteine and risk of dementia in Japan
title_full Serum homocysteine and risk of dementia in Japan
title_fullStr Serum homocysteine and risk of dementia in Japan
title_full_unstemmed Serum homocysteine and risk of dementia in Japan
title_short Serum homocysteine and risk of dementia in Japan
title_sort serum homocysteine and risk of dementia in japan
topic Neuropsychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231445/
https://www.ncbi.nlm.nih.gov/pubmed/32234968
http://dx.doi.org/10.1136/jnnp-2019-322366
work_keys_str_mv AT chensanmei serumhomocysteineandriskofdementiainjapan
AT hondatakanori serumhomocysteineandriskofdementiainjapan
AT oharatomoyuki serumhomocysteineandriskofdementiainjapan
AT hatajun serumhomocysteineandriskofdementiainjapan
AT hirakawayoichiro serumhomocysteineandriskofdementiainjapan
AT yoshidadaigo serumhomocysteineandriskofdementiainjapan
AT shibatamao serumhomocysteineandriskofdementiainjapan
AT sakatasatoko serumhomocysteineandriskofdementiainjapan
AT oishiemi serumhomocysteineandriskofdementiainjapan
AT furutayoshihiko serumhomocysteineandriskofdementiainjapan
AT kitazonotakanari serumhomocysteineandriskofdementiainjapan
AT ninomiyatoshiharu serumhomocysteineandriskofdementiainjapan